CTNNAP1, found downregulated in 70% of CRC tumors, correlates with advanced TNM staging and acts as a ceRNA, modulating CTNNA1 expression through miRNA‐141 decoy activity. This evidence concerns the gene CTNNA1 and colorectal carcinoma.